APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Abdominal Aortic Aneurysm Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Abdominal Aortic Aneurysm Drug Market Analysis and Forecast 2026-2032

Report ID 173959330219 December 2025191 pages

Choose your research edition.

Industry ResearchAbdominal Aortic Aneurysm Drug Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Abdominal Aortic Aneurysm Drug Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Abdominal Aortic Aneurysm Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Abdominal Aortic Aneurysm Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Abdominal Aortic Aneurysm Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Abdominal Aortic Aneurysm Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Abdominal Aortic Aneurysm Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Abdominal Aortic Aneurysm Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Abdominal Aortic Aneurysm Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Abdominal Aortic Aneurysm Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Abdominal Aortic Aneurysm Drug include Novartis AG, AstraZeneca Plc, Vida Therapeutics Inc. and Carolus Therapeutics, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Abdominal Aortic Aneurysm Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Abdominal Aortic Aneurysm Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Abdominal Aortic Aneurysm Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Abdominal Aortic Aneurysm Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Abdominal Aortic Aneurysm Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Abdominal Aortic Aneurysm Drug sales, projected growth trends, production technology, application and end-user industry.

Abdominal Aortic Aneurysm Drug Segment by Company

Novartis AG

AstraZeneca Plc

Vida Therapeutics Inc.

Carolus Therapeutics, Inc.

Abdominal Aortic Aneurysm Drug Segment by Type

BSN-908

Ticagrelor

Canakinumab

CT-2009

Others

Abdominal Aortic Aneurysm Drug Segment by Application

Hospital

Clinic

Others

Abdominal Aortic Aneurysm Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Abdominal Aortic Aneurysm Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Abdominal Aortic Aneurysm Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Abdominal Aortic Aneurysm Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Abdominal Aortic Aneurysm Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Abdominal Aortic Aneurysm Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Abdominal Aortic Aneurysm Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BSN-908 Major Manufacturers Table 3. Ticagrelor Major Manufacturers Table 4. Canakinumab Major Manufacturers Table 5. CT-2009 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Abdominal Aortic Aneurysm Drug Industry Trends Table 12. Abdominal Aortic Aneurysm Drug Industry Drivers Table 13. Abdominal Aortic Aneurysm Drug Industry Opportunities and Challenges Table 14. Abdominal Aortic Aneurysm Drug Industry Restraints Table 15. Global Abdominal Aortic Aneurysm Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2021-2026) Table 19. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2027-2032) Table 20. Global Abdominal Aortic Aneurysm Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Abdominal Aortic Aneurysm Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Abdominal Aortic Aneurysm Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2021-2026) Table 24. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2027-2032) Table 25. Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Abdominal Aortic Aneurysm Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Abdominal Aortic Aneurysm Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Abdominal Aortic Aneurysm Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Abdominal Aortic Aneurysm Drug Manufacturers, Product Type & Application Table 33. Global Abdominal Aortic Aneurysm Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Abdominal Aortic Aneurysm Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Abdominal Aortic Aneurysm Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2021-2026) Table 40. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2027-2032) Table 41. Global Abdominal Aortic Aneurysm Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2021-2026) Table 45. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2027-2032) Table 46. Global Abdominal Aortic Aneurysm Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Abdominal Aortic Aneurysm Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Abdominal Aortic Aneurysm Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2021-2026) Table 52. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2027-2032) Table 53. Global Abdominal Aortic Aneurysm Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2021-2026) Table 57. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2027-2032) Table 58. Global Abdominal Aortic Aneurysm Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Abdominal Aortic Aneurysm Drug Price by Application (2027-2032) & (US$/Unit) Table 60. Novartis AG Company Information Table 61. Novartis AG Business Overview Table 62. Novartis AG Abdominal Aortic Aneurysm Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Novartis AG Abdominal Aortic Aneurysm Drug Product Portfolio Table 64. Novartis AG Recent Development Table 65. AstraZeneca Plc Company Information Table 66. AstraZeneca Plc Business Overview Table 67. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product Portfolio Table 69. AstraZeneca Plc Recent Development Table 70. Vida Therapeutics Inc. Company Information Table 71. Vida Therapeutics Inc. Business Overview Table 72. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product Portfolio Table 74. Vida Therapeutics Inc. Recent Development Table 75. Carolus Therapeutics, Inc. Company Information Table 76. Carolus Therapeutics, Inc. Business Overview Table 77. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product Portfolio Table 79. Carolus Therapeutics, Inc. Recent Development Table 80. North America Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 83. North America Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 84. North America Abdominal Aortic Aneurysm Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 85. North America Abdominal Aortic Aneurysm Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 86. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 89. North America Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 90. North America Abdominal Aortic Aneurysm Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 91. North America Abdominal Aortic Aneurysm Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 92. North America Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 94. North America Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 95. North America Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 96. North America Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026) & (K Units) Table 97. North America Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032) & (K Units) Table 98. North America Abdominal Aortic Aneurysm Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 99. North America Abdominal Aortic Aneurysm Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 100. United States Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 101. Canada Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 102. Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 105. Europe Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 106. Europe Abdominal Aortic Aneurysm Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe Abdominal Aortic Aneurysm Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 111. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 112. Europe Abdominal Aortic Aneurysm Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe Abdominal Aortic Aneurysm Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026) & (K Units) Table 119. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032) & (K Units) Table 120. Europe Abdominal Aortic Aneurysm Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe Abdominal Aortic Aneurysm Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 123. France Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 124. U.K. Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 125. Italy Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 127. China Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 128. China Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 129. China Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 130. China Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 131. China Abdominal Aortic Aneurysm Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 132. China Abdominal Aortic Aneurysm Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 133. China Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 134. China Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 135. China Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 136. China Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 137. China Abdominal Aortic Aneurysm Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 138. China Abdominal Aortic Aneurysm Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 142. Asia Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 143. Asia Abdominal Aortic Aneurysm Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Asia Abdominal Aortic Aneurysm Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Asia Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 148. Asia Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 149. Asia Abdominal Aortic Aneurysm Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Asia Abdominal Aortic Aneurysm Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Asia Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026) & (K Units) Table 156. Asia Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032) & (K Units) Table 157. Asia Abdominal Aortic Aneurysm Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Asia Abdominal Aortic Aneurysm Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Japan Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 160. South Korea Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 161. India Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 162. Australia Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 163. China Taiwan Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Abdominal Aortic Aneurysm Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Abdominal Aortic Aneurysm Drug Sales by Type (2021-2026) & (K Units) Table 168. SAMEA Abdominal Aortic Aneurysm Drug Sales by Type (2027-2032) & (K Units) Table 169. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 170. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 171. SAMEA Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Abdominal Aortic Aneurysm Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Abdominal Aortic Aneurysm Drug Sales by Application (2021-2026) & (K Units) Table 174. SAMEA Abdominal Aortic Aneurysm Drug Sales by Application (2027-2032) & (K Units) Table 175. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 176. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 177. SAMEA Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. SAMEA Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026) & (K Units) Table 182. SAMEA Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032) & (K Units) Table 183. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 184. SAMEA Abdominal Aortic Aneurysm Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Brazil Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 186. Argentina Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 187. Chile Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 188. Colombia Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 189. Peru Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 191. Israel Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 192. UAE Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 193. Turkey Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 194. Iran Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 195. Egypt Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Abdominal Aortic Aneurysm Drug Distributors List Table 199. Abdominal Aortic Aneurysm Drug Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Abdominal Aortic Aneurysm Drug Image Figure 2. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Abdominal Aortic Aneurysm Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. BSN-908 Image Figure 5. Ticagrelor Image Figure 6. Canakinumab Image Figure 7. CT-2009 Image Figure 8. Others Image Figure 9. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Abdominal Aortic Aneurysm Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Abdominal Aortic Aneurysm Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Abdominal Aortic Aneurysm Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Abdominal Aortic Aneurysm Drug Sales (2021-2032) & (K Units) Figure 20. Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Abdominal Aortic Aneurysm Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Abdominal Aortic Aneurysm Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Abdominal Aortic Aneurysm Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Abdominal Aortic Aneurysm Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Abdominal Aortic Aneurysm Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Abdominal Aortic Aneurysm Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Abdominal Aortic Aneurysm Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Abdominal Aortic Aneurysm Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2021-2032) Figure 36. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Abdominal Aortic Aneurysm Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2021-2032) Figure 42. North America Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2032) Figure 43. North America Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2032) Figure 44. North America Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2032) Figure 45. North America Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2032) Figure 46. North America Abdominal Aortic Aneurysm Drug Revenue Share by Country (2021-2032) Figure 47. North America Abdominal Aortic Aneurysm Drug Sales Share by Country (2021-2032) Figure 48. Europe Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2032) Figure 49. Europe Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2032) Figure 50. Europe Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2032) Figure 51. Europe Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2032) Figure 52. Europe Abdominal Aortic Aneurysm Drug Revenue Share by Country (2021-2032) Figure 53. Europe Abdominal Aortic Aneurysm Drug Sales Share by Country (2021-2032) Figure 54. China Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2032) Figure 55. China Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2032) Figure 56. China Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2032) Figure 57. China Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2032) Figure 58. Asia Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2032) Figure 59. Asia Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2032) Figure 60. Asia Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2032) Figure 61. Asia Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2032) Figure 62. Asia Abdominal Aortic Aneurysm Drug Revenue Share by Country (2021-2032) Figure 63. Asia Abdominal Aortic Aneurysm Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Abdominal Aortic Aneurysm Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Abdominal Aortic Aneurysm Drug Sales Share by Country (2021-2032) Figure 70. Abdominal Aortic Aneurysm Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Abdominal Aortic Aneurysm Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BSN-908
  • Ticagrelor
  • Canakinumab
  • CT-2009
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • AstraZeneca Plc
  • Vida Therapeutics Inc.
  • Carolus Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Abdominal Aortic Aneurysm Drug Market by Type
  3. 1.2.1 Global Abdominal Aortic Aneurysm Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BSN-908
  5. 1.2.3 Ticagrelor
  6. 1.2.4 Canakinumab
  7. 1.2.5 CT-2009
  8. 1.2.6 Others
  9. 1.3 Abdominal Aortic Aneurysm Drug Market by Application
  10. 1.3.1 Global Abdominal Aortic Aneurysm Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Abdominal Aortic Aneurysm Drug Market Dynamics
  1. 2.1 Abdominal Aortic Aneurysm Drug Industry Trends
  2. 2.2 Abdominal Aortic Aneurysm Drug Industry Drivers
  3. 2.3 Abdominal Aortic Aneurysm Drug Industry Opportunities and Challenges
  4. 2.4 Abdominal Aortic Aneurysm Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Abdominal Aortic Aneurysm Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Abdominal Aortic Aneurysm Drug Revenue by Region
  3. 3.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Abdominal Aortic Aneurysm Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Abdominal Aortic Aneurysm Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Abdominal Aortic Aneurysm Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Abdominal Aortic Aneurysm Drug Sales by Region
  9. 3.4.1 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Abdominal Aortic Aneurysm Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Abdominal Aortic Aneurysm Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers
  2. 4.1.1 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Abdominal Aortic Aneurysm Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers
  6. 4.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Abdominal Aortic Aneurysm Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Abdominal Aortic Aneurysm Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Abdominal Aortic Aneurysm Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Abdominal Aortic Aneurysm Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Abdominal Aortic Aneurysm Drug Manufacturers, Product Type & Application
  13. 4.7 Global Abdominal Aortic Aneurysm Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Abdominal Aortic Aneurysm Drug Market CR5 and HHI
  16. 4.8.2 2025 Abdominal Aortic Aneurysm Drug Tier 1, Tier 2, and Tier 3
5 Abdominal Aortic Aneurysm Drug Market by Type
  1. 5.1 Global Abdominal Aortic Aneurysm Drug Revenue by Type
  2. 5.1.1 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Abdominal Aortic Aneurysm Drug Sales by Type
  6. 5.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Abdominal Aortic Aneurysm Drug Price by Type
6 Abdominal Aortic Aneurysm Drug Market by Application
  1. 6.1 Global Abdominal Aortic Aneurysm Drug Revenue by Application
  2. 6.1.1 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Abdominal Aortic Aneurysm Drug Sales by Application
  6. 6.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Abdominal Aortic Aneurysm Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Abdominal Aortic Aneurysm Drug Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 AstraZeneca Plc
  8. 7.2.1 AstraZeneca Plc Company Information
  9. 7.2.2 AstraZeneca Plc Business Overview
  10. 7.2.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product Portfolio
  12. 7.2.5 AstraZeneca Plc Recent Developments
  13. 7.3 Vida Therapeutics Inc.
  14. 7.3.1 Vida Therapeutics Inc. Company Information
  15. 7.3.2 Vida Therapeutics Inc. Business Overview
  16. 7.3.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product Portfolio
  18. 7.3.5 Vida Therapeutics Inc. Recent Developments
  19. 7.4 Carolus Therapeutics, Inc.
  20. 7.4.1 Carolus Therapeutics, Inc. Company Information
  21. 7.4.2 Carolus Therapeutics, Inc. Business Overview
  22. 7.4.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product Portfolio
  24. 7.4.5 Carolus Therapeutics, Inc. Recent Developments
8 North America
  1. 8.1 North America Abdominal Aortic Aneurysm Drug Market Size by Type
  2. 8.1.1 North America Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Abdominal Aortic Aneurysm Drug Price by Type (2021-2032)
  5. 8.2 North America Abdominal Aortic Aneurysm Drug Market Size by Application
  6. 8.2.1 North America Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Abdominal Aortic Aneurysm Drug Price by Application (2021-2032)
  9. 8.3 North America Abdominal Aortic Aneurysm Drug Market Size by Country
  10. 8.3.1 North America Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Abdominal Aortic Aneurysm Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Abdominal Aortic Aneurysm Drug Market Size by Type
  2. 9.1.1 Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Abdominal Aortic Aneurysm Drug Price by Type (2021-2032)
  5. 9.2 Europe Abdominal Aortic Aneurysm Drug Market Size by Application
  6. 9.2.1 Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Abdominal Aortic Aneurysm Drug Price by Application (2021-2032)
  9. 9.3 Europe Abdominal Aortic Aneurysm Drug Market Size by Country
  10. 9.3.1 Europe Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Abdominal Aortic Aneurysm Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Abdominal Aortic Aneurysm Drug Market Size by Type
  2. 10.1.1 China Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032)
  4. 10.1.3 China Abdominal Aortic Aneurysm Drug Price by Type (2021-2032)
  5. 10.2 China Abdominal Aortic Aneurysm Drug Market Size by Application
  6. 10.2.1 China Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032)
  8. 10.2.3 China Abdominal Aortic Aneurysm Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Abdominal Aortic Aneurysm Drug Market Size by Type
  2. 11.1.1 Asia Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Abdominal Aortic Aneurysm Drug Price by Type (2021-2032)
  5. 11.2 Asia Abdominal Aortic Aneurysm Drug Market Size by Application
  6. 11.2.1 Asia Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Abdominal Aortic Aneurysm Drug Price by Application (2021-2032)
  9. 11.3 Asia Abdominal Aortic Aneurysm Drug Market Size by Country
  10. 11.3.1 Asia Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Abdominal Aortic Aneurysm Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Abdominal Aortic Aneurysm Drug Market Size by Type
  2. 12.1.1 SAMEA Abdominal Aortic Aneurysm Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Abdominal Aortic Aneurysm Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Abdominal Aortic Aneurysm Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Abdominal Aortic Aneurysm Drug Market Size by Application
  6. 12.2.1 SAMEA Abdominal Aortic Aneurysm Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Abdominal Aortic Aneurysm Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Abdominal Aortic Aneurysm Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Abdominal Aortic Aneurysm Drug Market Size by Country
  10. 12.3.1 SAMEA Abdominal Aortic Aneurysm Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Abdominal Aortic Aneurysm Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Abdominal Aortic Aneurysm Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Abdominal Aortic Aneurysm Drug Value Chain Analysis
  2. 13.1.1 Abdominal Aortic Aneurysm Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Abdominal Aortic Aneurysm Drug Production Mode & Process
  6. 13.2 Abdominal Aortic Aneurysm Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Abdominal Aortic Aneurysm Drug Distributors
  9. 13.2.3 Abdominal Aortic Aneurysm Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst